Manuel Hidalgo
Manuel Hidalgo
Weill Cornell Medicine
Dirección de correo verificada de med.cornell.edu
Título
Citado por
Citado por
Año
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
DD Von Hoff, T Ervin, FP Arena, EG Chiorean, J Infante, M Moore, T Seay, ...
New England Journal of Medicine 369 (18), 1691-1703, 2013
39002013
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
S Jones, X Zhang, DW Parsons, JCH Lin, RJ Leary, P Angenendt, ...
science 321 (5897), 1801-1806, 2008
37372008
Pancreatic cancer
M Hidalgo
New England Journal of Medicine 362 (17), 1605-1617, 2010
27902010
A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development
A Jimeno, G Feldmann, A Suárez-Gauthier, Z Rasheed, A Solomon, ...
Molecular cancer therapeutics 8 (2), 310-314, 2009
1380*2009
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab
S Khambata-Ford, CR Garrett, NJ Meropol, M Basik, CT Harbison, S Wu, ...
Journal of clinical oncology 25 (22), 3230-3237, 2007
12602007
Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations
DM Hyman, I Puzanov, V Subbiah, JE Faris, I Chau, JY Blay, J Wolf, ...
New England Journal of Medicine 373 (8), 726-736, 2015
11742015
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
M Hidalgo, LL Siu, J Nemunaitis, J Rizzo, LA Hammond, C Takimoto, ...
Journal of clinical oncology 19 (13), 3267-3279, 2001
11662001
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma
MB Atkins, M Hidalgo, WM Stadler, TF Logan, JP Dutcher, GR Hudes, ...
Journal of clinical oncology 22 (5), 909-918, 2004
11162004
Development of matrix metalloproteinase inhibitors in cancer therapy
M Hidalgo, SG Eckhardt
Journal of the National Cancer Institute 93 (3), 178-193, 2001
9722001
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial
DD Von Hoff, RK Ramanathan, MJ Borad, DA Laheru, LS Smith, TE Wood, ...
Journal of Clinical Oncology 29 (34), 4548, 2011
9182011
Patient-derived xenograft models: an emerging platform for translational cancer research
M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ...
Cancer discovery 4 (9), 998-1013, 2014
9152014
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of …
D Soulieres, NN Senzer, EE Vokes, M Hidalgo, SS Agarwala, LL Siu
Journal of clinical oncology 22 (1), 77-85, 2004
8972004
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer
CA Iacobuzio-Donahue, B Fu, S Yachida, M Luo, H Abe, CM Henderson, ...
Journal of clinical oncology 27 (11), 1806, 2009
8592009
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study
E Galanis, JC Buckner, MJ Maurer, JI Kreisberg, K Ballman, J Boni, ...
Journal of Clinical Oncology 23 (23), 5294-5304, 2005
7702005
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
M Hidalgo, EK Rowinsky
Oncogene 19 (56), 6680-6686, 2000
7052000
Developing inhibitors of the epidermal growth factor receptor for cancer treatment
V Grunwald, M Hidalgo
Journal of the National Cancer Institute 95 (12), 851-867, 2003
6192003
Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity
LA DeGraffenried, WE Friedrichs, DH Russell, EJ Donzis, AK Middleton, ...
Clinical cancer research 10 (23), 8059-8067, 2004
4352004
Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma
ZA Rasheed, J Yang, Q Wang, J Kowalski, I Freed, C Murter, SM Hong, ...
Journal of the National Cancer Institute 102 (5), 340-351, 2010
4262010
Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
I Garrido-Laguna, M Hidalgo
Nature reviews Clinical oncology 12 (6), 319, 2015
4182015
An in vivo platform for translational drug development in pancreatic cancer
B Rubio-Viqueira, A Jimeno, G Cusatis, X Zhang, C Iacobuzio-Donahue, ...
Clinical cancer research 12 (15), 4652-4661, 2006
4012006
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20